EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay

Konstantinos Arvanitakis iD, Elena Chatzikalil, Georgios Kalopitas iD, Dimitrios Patoulias iD, Djordje S Popovic iD, Symeon Metallidis, Kalliopi Kotsa iD, Georgios Germanidis iD, Theocharis Koufakis iD

Journal of Clinical Medicine · 20.07.2024 · 13 (14) · 4243

DOI: 10.3390/jcm13144243 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.07.2024. Verfasst von Konstantinos Arvanitakis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, First Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, …. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) and polycystic ovary syndrome (PCOS) are prevalent conditions that have been correlated with infertility through overlapped pathophysiological mechanisms. MASLD is associated with metabolic syndrome and is considered among the major causes of chronic liver disease, while PCOS, which is characterized by ovulatory dysfunction and hyperandrogenism, is one of the leading causes of female infertility. The pathophysiological links between PCOS and MASLD have not yet been fully elucidated, with insulin resistance, hyperandrogenemia, obesity, and dyslipidemia being among the key pathways that contribute to liver lipid accumulation, inflammation, and fibrosis, aggravating liver dysfunction. On the other hand, MASLD exacerbates insulin resistance and metabolic dysregulation in women with PCOS, creating a vicious cycle of disease progression. Understanding the intricate relationship between MASLD and PCOS is crucial to improving clinical management, while collaborative efforts between different medical specialties are essential to optimize fertility and liver health outcomes in individuals with MASLD and PCOS. In this review, we summarize the complex interplay between MASLD and PCOS, highlighting the importance of increasing clinical attention to the prevention, diagnosis, and treatment of both entities.

Schlagwörter

Stichwörter der Autor:innen

MASLDPCOSinfertilityobesityoverweight

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, First Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kiriakidi 1, 54636 Thessaloniki, Greece.
  • Basic and Translational Research Unit, Special Unit for Biomedical Research and Education, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
  • Athens Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Second Propaedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
  • Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Centre of Vojvodina, 21000 Novi Sad, Serbia.
  • Medical Faculty, University of Novi Sad, 21000 Novi Sad, Serbia.

ORCID-Profile: Konstantinos Arvanitakis, Georgios Kalopitas, Dimitrios Patoulias, Djordje S Popovic, Kalliopi Kotsa, Georgios Germanidis, Theocharis Koufakis

Zitieren

APA

Arvanitakis, K., Chatzikalil, E., Kalopitas, G., Patoulias, D., Popovic, D. S., Metallidis, S., Kotsa, K., Germanidis, G., & Koufakis, T. (2024). Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay. Journal of Clinical Medicine, 13(14), 4243. https://doi.org/10.3390/jcm13144243

Vancouver

Arvanitakis K, Chatzikalil E, Kalopitas G, Patoulias D, Popovic DS, Metallidis S, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay. Journal of Clinical Medicine. 2024;13(14):4243. doi:10.3390/jcm13144243

BibTeX
@article{Arvanitakis2024,
  author = {Arvanitakis, Konstantinos and Chatzikalil, Elena and Kalopitas, Georgios and Patoulias, Dimitrios and Popovic, Djordje S and Metallidis, Symeon and Kotsa, Kalliopi and Germanidis, Georgios and Koufakis, Theocharis},
  title = {Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {14},
  pages = {4243},
  doi = {10.3390/jcm13144243}
}
Kostenlos starten →